openPR Logo
Press release

Pet Ownership Dynamics A Catalyst For Growth In Veterinary Vaccines: Transformative Forces Shaping the Companion Animal Veterinary Vaccines Market Landscape in 2025

08-19-2025 09:19 AM CET | Health & Medicine

Press release from: The Business Research Company

Companion Animal Veterinary Vaccines

Companion Animal Veterinary Vaccines

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Companion Animal Veterinary Vaccines Industry Market Size Be by 2025?
The size of the companion animal veterinary vaccines market has seen robust growth in the past few years. The market value is predicted to rise from $3.66 billion in 2024 to $3.88 billion in 2025, maintaining a compound annual growth rate (CAGR) of 6.0%. The exceptional growth observed in the historical period is because of factors such as increased pet ownership, preventive healthcare measures, prevalence of zoonotic diseases, and advancements in vaccine technology.

What's the Long-Term Growth Forecast for the Companion Animal Veterinary Vaccines Market Size Through 2029?
The market for veterinary vaccines for companion animals is projected to experience significant expansion in the coming years. It's anticipated to reach $5.09 billion by 2029, advancing at a compound annual growth rate (CAGR) of 7.0%. The robust growth predicted within this period can be linked to factors such as a growing pet population, enhanced awareness of preventative healthcare, advancements in technology and vaccine development, as well as personalized vaccination plans. Key trends for the forecast period encompass broad vaccination programs, cutting-edge vaccine technologies, control of vector-transmitted diseases, vaccination facilities, and mobile services.

View the full report here:
https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

What Are the Key Growth Drivers Fueling the Companion Animal Veterinary Vaccines Market Expansion?
The companion animal veterinary vaccine market's expansion in the forecast period can be credited to the rise in pet ownership primarily amongst Gen X and Gen Y adults. As per the APPA, millennials (Gen Y) make up the largest group of pet owners of various animals. More than 80% of individuals from Gen Y and Gen Z own dogs, and less than half own cats. Furthermore, the trend of owning multiple pets is climbing in many parts of the globe. For example, in 2022, as reported by Animal Medicines Australia, a non-governmental organization based in Australia, the rate of pet ownership saw significant growth, with pet owners standing at 28,730.8 in 2022, a rise from 39% in 2021. This signifies a 24% increase, indicating a substantial rising trend in pet adoption and spendings on their care. The spike in pet ownership highlights the escalating fondness for pets in Australian households. This increase in pet ownership is fueling the growth of the companion animal veterinary vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3370&type=smp

What Are the Key Trends Driving Companion Animal Veterinary Vaccines Market Growth?
The trend of collaborating and forming partnerships with other entities in the industry has been on the rise among companies in the companion animal veterinary vaccine market, as a strategy to fuel innovation in their products. Companies in this increasingly competitive marketplace are venturing into new territories and crafting innovative products by pooling together their expertise and skills with other players. For example, MSD Animal Health, a subsidiary of Merck & Co., recently publicized their strategic partnership with Vinovo B.V., a segment of Viscon Hatchery Automation, a leading firm in hatchery automation. Their goal is to set a new benchmark in secure and effective Vinovo vaccination, aiming to enhance bird welfare and mitigate vaccine reactions.

How Is the Companion Animal Veterinary Vaccines Market Segmented?
The companion animal veterinary vaccines market covered in this report is segmented -

1) By Product: Inactivated, Live Attenuated, Recombinant, Other Products
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels

Subsegments:
1) By Inactivated: Inactivated Canine Vaccines, Inactivated Feline Vaccines, Inactivated Vaccine Combinations, Other Inactivated Vaccines
2) By Live Attenuated: Live Attenuated Canine Vaccines, Live Attenuated Feline Vaccines, Live Attenuated Vaccine Combinations, Other Live Attenuated Vaccines
3) By Recombinant: Recombinant Canine Vaccines, Recombinant Feline Vaccines, Recombinant Vaccine Combinations, Other Recombinant Vaccines
4) By Other Products: DNA Vaccines, Subunit Vaccines, Toxoid Vaccines, Other Veterinary Vaccine Products

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3370&type=smp

Which Companies Are Leading the Charge in Companion Animal Veterinary Vaccines Market Innovation?
Major companies operating in the companion animal veterinary vaccines market include C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, Heska Corp., Merck and Co. Inc., Elanco Animal Health Incorporated, Zoetis Inc., Ceva Sante Animale SA, Bayer AG, Neogen Corporation, ImmuCell Corporation, Intervet Inc., Vetoquinol SA, IDEXX Laboratories Inc., Merial Inc., Biogenesis Bago SA, Hipra India Pvt. Ltd., Bimeda Animal Health Limited, Phibro Animal Health Corporation, Nexvet Biopharma plc, Bioniche Animal Health Canada Inc., Bioiberica S.A., Laboratorios Hipra S.A., Norbrook Laboratories Ltd., Dechra Pharmaceuticals PLC, Kyoritsu Seiyaku Corporation, VDS Pharma Animal Health, Kepro Technologies Private Limited, ECO Animal Health Group plc, Biostadt India Limited, bio-pharmaceutical company, Choong Ang Vaccine Laboratories Co. Ltd., CZ Veterinaria S.A.

Which Regions Are Leading the Global Companion Animal Veterinary Vaccines Market in Revenue?
North America was the largest region in the companion animal veterinary vaccines market in 2023. Asia-Pacific was the second-largest region in the companion animal veterinary vaccines market. The regions covered in the companion animal veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3370

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pet Ownership Dynamics A Catalyst For Growth In Veterinary Vaccines: Transformative Forces Shaping the Companion Animal Veterinary Vaccines Market Landscape in 2025 here

News-ID: 4149137 • Views:

More Releases from The Business Research Company

Navigating the Future: Dental X-Ray Equipment Market Trends and Forecast Insights, 2025 Edition
Navigating the Future: Dental X-Ray Equipment Market Trends and Forecast Insight …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Dental X-Ray Equipment Market Size Growth Forecast: What to Expect by 2025? The market size for dental x-ray equipment has experienced swift expansion in the past few years. The value is projected to escalate from $2.87 billion in 2024 to around $3.26 billion in 2025, boasting a compound annual
Vitrectomy Devices Industry Outlook 2025-2029: Market Set to Cross $2.42 Billion Milestone
Vitrectomy Devices Industry Outlook 2025-2029: Market Set to Cross $2.42 Billion …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Vitrectomy Devices Market Size By 2025? In recent times, the vitrectomy devices market has demonstrated a robust growth pattern. The current projection indicates an incrrease from $1.66 billion in 2024 to $1.74 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 5.1%.
Innovative Sensors Revolutionize The Cerebrospinal Fluid (CSF) Devices Market For Enhanced Diagnosis And Treatment Industry Trends Gaining Momentum in the Global Cerebrospinal Fluid Management (CSF) Devices And Equipment Market
Innovative Sensors Revolutionize The Cerebrospinal Fluid (CSF) Devices Market Fo …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Cerebrospinal Fluid Management (CSF) Devices And Equipment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for cerebrospinal fluid management (csf) devices and equipment has seen robust growth in the past few years. The market size is projected to increase from $1.15 billion in
Key Trends Reshaping the Thrombectomy Devices Market: The Rise Of Technological Innovations In Thrombectomy Devices Market Industry Transformation
Key Trends Reshaping the Thrombectomy Devices Market: The Rise Of Technological …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Thrombectomy Devices Market Size Growth Forecast: What to Expect by 2025? The market for thrombectomy devices has seen robust growth in the past few years. It is predicted to expand from a value of $1.54 billion in 2024 to $1.64 billion in 2025, boasting a compound annual growth rate

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion